MRNA earnings per share for the last quarter are 0.03 EUR whereas the estimation was -1.62 EUR which accounts for 101.66% surprise. Company revenue for the same period amounts to 1.67 B EUR despite the estimated figure of 1.12 B EUR. Estimated earnings per share for the next quarter are -2.67 EUR, and revenue is expected to reach 956.85 M EUR. Also watch annual changes over time to get a bigger picture of MRNA earnings per share and revenue dynamics.